TRINTELLIX: payments to doctors
Payments that named TRINTELLIX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.7M
- Providers
- 62,646
- Transactions
- 358,646
- Average per transaction
- $21
The per-transaction average — $21 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 62,646 providers the average total is $122, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $7,622,282 | 99.5% |
| Shire North American Group Inc | $29,119 | 0.4% |
| Takeda Pharmaceutical Company, Limited | $5,368 | 0.1% |